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ABSTRACT. Hepatocyte growth factor (HGF) prevents liver failure in various animal models including
endotoxin-induced acute liver failure. We were interested to find out whether human HGF exerts anti-
inflammatory effects by modulation of cytokine synthesis. Therefore, human HepG2 cells were cultured with
increasing concentrations of HGF. HGF dose-dependently upregulated the production of interleukin-1 receptor
antagonist (IL-1Ra). Incubation of HepG2 cells with interleukin-1b (IL-1b) caused an increase in IL-1Ra levels,
while interleukin-6 (IL-6) had no effect on IL-1Ra synthesis. Co-stimulation of HepG2 cells with HGF + IL-1b
resulted in a synergistic effect on IL-1Ra mRNA and protein expression. Stimulation of freshly isolated mouse
hepatocytes from male C57 BL/6 mice with HGF increased IL-1Ra mRNA and protein synthesis dose-
dependently. A co-stimulation with HGF and IL-1b had a synergistic effect on IL-1Ra mRNA expression but only
a partially additive effect on IL-1Ra protein synthesis. HGF-induced IL-1Ra production was significantly
decreased by the mitogen-activated protein kinase (MAPK) inhibitor PD98059. Accordingly, HGF stimulation
specifically increased MAPK-dependent signalling pathway (p42/44). In contrast, in preactivated PBMC mRNA
expression and protein synthesis of IL-1Ra, interleukin-10 (IL-10) and tumor necrosis factor-a (TNF-a) were
unaffected after stimulation with HGF. In conclusion, our data suggest that HGF exerts anti-inflammatory effects
by modulating the signal transduction cascade leading to increased expression of IL-1Ra, which might explain the
protective and regenerative properties of this cytokine in animal models of liver failure.
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INTRODUCTION
Hepatocyte growth factor (HGF) is the most potent mito-
gen for mature parenchymal hepatocytes in primary cul-
ture [1], and seems to be a hepatotrophic factor that acts as
a trigger for liver regeneration after partial hepatectomy
and liver injury [2, 3]. Several reports have shown that
HGF is a multifunctional and pleiotropic cytokine affect-
ing various target cells [4-7]. HGF acts as a mitogen,
morphogen and motogen [4-7]. HGF has been shown to
prevent liver failure in various models, acting as an anti-
hepatitis cytokine [8, 9]. Rats injected intravenously with
HGF showed reduced hepatotoxic responses to
a-naphthylisothiocyanate administration [8]. These results
were confirmed by Ishiki et al., who demonstrated
protective effects of HGF in mice injected with
a-naphthylisothiocyanate or CCl4 [9]. Some of the pos-
sible mechanisms for these protective properties of HGF,
such as increased hepatic prostaglandin (PG) E2 produc-
tion following D-galactosamine administration, and sup-
pressed activation of the Fas and Fas ligand system, have
been elucidated [10, 11]. Interaction with the cytokine
cascade could be another mode of action.
The liver is thought to play a central role in limiting local
and systemic inflammation. Indeed, a hepatocyte-specific
inhibitor of RNA and protein synthesis, D-galactosamine,
sensitizes animals to the lethal effects of lipopolysaccha-
ride (LPS) and tumor necrosis factor (TNF), suggesting
that proteins synthesized in the liver in response to LPS
and inflammatory cytokines somehow attenuate the bio-
logical effects of these mediators [12, 13]. TNF is a proto-
typic, pro-inflammatory cytokine, which has been demon-
strated to be of importance in animal models of acute liver
failure [14]. Gene transfer with human TNF receptor p55,
a natural inhibitor of TNF, has been shown to reduce
mortality in lethal endotoxemia and thereby to attenuate
liver inflammation [15]. On the other hand it has been
demonstrated that the prototype anti-inflammatory cytok-
ine, namely interleukin-10 (IL-10), is also able to prevent
experimental liver failure [15, 16]. Recently, it has been
shown in a mouse model of turpentine-induced inflamma-
tion, that the magnitude of the nonspecific inflammatory
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response and its successful outcome results from the bal-
ance between interleukin-1 (IL-1) and interleukin-1 recep-
tor antagonist (IL-1Ra) [17]. The physiological function of
IL-1Ra has been demonstrated using IL-1Ra-knockout
mice, which were more susceptible to lethal endotoxemia
than wild-type mice [18]. In an animal model of experi-
mental hepatitis, the protective role of IL-1Ra was demon-
strated using blocking monoclonal antibodies against IL-
1Ra [19]. The elevated ratio of IL-1Ra to IL-1b in patients
with fulminant hepatic failure who survived compared
with those who died also suggests a protective role for
IL-1Ra in liver failure [20]. Therefore, besides HGF, a
whole panel of pro- and anti-inflammatory cytokines
seems to be involved in the pathophysiology of acute liver
injury.
It is well known that pro-inflammatory cytokines such as
IL-1a and IL-1b enhance HGF gene expression in vitro
[21, 22]. In contrast however, it is not known whether HGF
is able to modulate cytokine synthesis. In the present study,
we examined the production of the acute phase protein
IL-1Ra by HepG2 cells and by mouse hepatocytes, in
response to HGF treatment. Beilmann et al. demonstrated
a marked induction of c-met HGF receptor expression in
activated monocytes, in particular under conditions resem-
bling inflammation, suggesting that HGF might activate
monocytes during inflammation and modulate specific
monocyte/macrophage functions at the site of the inflam-
matory reaction [23]. Therefore, we additionally examined
whether HGF affects production of the pro-inflammatory
cytokine TNF-a or the anti-inflammatory cytokines IL-10
and IL-1Ra in human mononuclear cells.
MATERIALS AND METHODS
Reagents
Recombinant human HGF was provided by Genentech
Inc. (South San Francisco, CA, USA). Phorbol 12-
myristate 13-acetate (PMA), phytohemagglutinin (PHA)
and endotoxin (LPS; E.coli 055:B5) as well as collagenase
and polymyxin B sulfate were from Sigma Chemical Co.
(Vienna, Austria). RPMI 1640 and phosphate-buffered sa-
line (PBS) were from Seromed (Biochrom KG, Berlin,
Germany). Minimal essential medium (MEM), fetal bo-
vine serum (FBS), non-essential amino acids, glutamine
and antibiotics (penicillin and streptomycin) were from
Invitrogen (Karlsruhe, Germany). IL-1b was from R&D
Systems (Minneapolis, USA). Mitogen-activated protein
kinase (MAPK)/extracellular regulated kinase kinase-1
(MEK-1) inhibitor PD98059 and p38-MAPK inhibitor
SB203580 were from Calbiochem (San Diego, CA, USA).
HepG2 cell culture
The human hepatocellular carcinoma cell line HepG2 was
obtained from the American Type Culture Collection (Be-
thesda, MD, USA) at passage number 76. The cells were
cultured in RPMI 1640 supplemented with 10% heat-
inactivated fetal calf serum (FCS), streptomycin
(100 mg/mL) and penicillin (100 units/mL). Cells were
grown at 37 °C in 75 cm2 plastic flasks in a humidified
atmosphere containing 5% CO2. The medium was re-
placed twice a week. Every seven days the cells were
trypsinized and subcultured at a ratio of 1:6. For experi-
ments, cells were seeded at a density of 0.7x106/mL in
six-well polystyrene plates containing 2 mL of medium.
All experiments were performed with addition of 5 lg/mL
polymyxin B to rule out the possibility that LPS-
contamination might stimulate IL-1Ra. HepG2 cells were
incubated for 48 h until they reached confluence, subse-
quenly medium was changed and respective cytokines
were added in RPMI 1640. Supernatants were collected
after 2 h, 4 h, 8 h, 12 h and 24 h and cytokine detection was
carried out using ELISA.
Mouse hepatocyte isolation and treatments
Hepatocytes were isolated from male C57 BL/6 mice
(three months old) by the two step EGTA-collagenase
perfusion method [24]. Cell viability was measured using
the Trypan blue-exclusion test: it was always above 90% in
all experiments. Cells were seeded at a density of 3x106
cells per dish onto collagen-coated 60 mm dishes in MEM
supplemented with 10% FBS plus non-essential amino
acids, glutamine and antibiotics (penicillin 100 units/mL
and streptomycin 100 mg/mL). After 2 h of culture, me-
dium was replaced by fresh medium without serum, and
then cells were treated with increasing concentrations of
HGF (0.1, 10, 100 ng/mL) and/or IL-1b (1 ng/mL) for the
indicated time periods (6 h for RNA isolation and 24 h for
ELISA). Supernatants were collected and cytokine detec-
tion was carried out using an ELISA.
Isolation of peripheral blood mononuclear cells
(PBMC)
PBMC were isolated from the heparinized blood from
healthy volunteers as previously described [25]. In all
experiments, except those with LPS, 5 lg/mL of poly-
myxin B were included in the culture medium. PMA and
PHA were used at a final concentration of 1 and 10 ng/mL.
As stimulation with PHA and LPS has been demonstrated
to cause an upregulation in HGF-receptor messenger RNA
(mRNA) [23], in some experiments PBMC were preincu-
bated for 15 h with PMA, PHA or LPS before addition of
HGF. The total incubation period in these experiments was
48 h. After incubation, PBMC cultures were frozen and
thawed three times to allow for the release of intracellular
cytokines. After centrifugation, cytokine detection was
carried out using an ELISA. The amount of IL-1Ra, IL-10
and TNF-a reported in these experiments represents the
total amount generated (secreted and cell-associated).
Elisa
Commercially available „sandwich“ ELISA kits were used
to determine cytokine levels in the supernatants and cell
lysates of HepG2 cells and PBMC Human TNF-a and
IL-1Ra were analysed using an ELISA obtained from
R&D Systems, and IL-10 was measured using an ELISA
obtained from CLB (Amsterdam, The Netherlands) ac-
cording to the manufacturer´s instructions. The lower de-
tection limit for these assays was 5 pg/mL, and they did not
show any cross-reactivity with various other cytokines.
Levels of murine IL-1Ra were measured in supernatants
from mouse primary hepatocytes using a modification of a
specific ELISA [26], as previously described [27].
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Northern blot analysis
HepG2 cells were seeded at a concentration of 0.7x106/mL
in a six-well plate for 48 h and then stimulated with HGF,
IL-6 ± HGF and IL-1b ± HGF for 4 h. The supernatants
were discarded and the cell monolayer was washed twice
with PBS. Then total RNA was then isolated by means of
the guanidinium-isothyocyanate phenol extraction method
using the RNA-Clean system (AGS GmbH, Heidelberg,
Germany) following the manufacturer´s instructions.
1x107 PBMC were suspended in RPMI 1640 and 5% FCS
and cultured for 4, 8, 12 and 20 h, respectively, after
stimulation with HGF, PMA ± HGF, PHA ± HGF or LPS ±
HGF. In parallel experiments, cells were preincubated with
PMA, PHA or LPS for 15 h and then stimulated with HGF
for an additional 5 h. PBMC were washed once with PBS.
Total cellular RNA was prepared as described above.
Northern blot analysis was performed as previously de-
scribed [25]. The TNF probe used was a 505-bp fragment
of the human TNF complementary DNA (cDNA) sub-
cloned in pUC18 (R&D Systems). The IL-1Ra probe was a
480-bp fragment of human IL-1Ra cDNA subcloned in
pUC18 (R&D Systems). The IL-10 probe was a fragment
of 1.6 kb of human IL-10 cDNA, subcloned in the plasmid
vector pcDSRalpha (ATCC, Bethesda, MD, USA).
Control-hybridizations were performed with the rat
cDNA of the housekeeping gene glyceraldehyde-3-
phosphatedehydrogenase (GAPDH).
Total RNA isolation in mouse hepatocytes
After stimulation, hepatocyte cultures were washed with
cold PBS, subsequently lysed in acid guanidinium-
isothyocyanate and total RNA was purified as described
[28]. The reverse transcriptase reaction was performed
with 1 lg of total RNA, random hexamers (Roche, Man-
nheim, Germany), and MMLV reverse transcriptase
(GIBCO, Gaithersburg, MD, USA) according to the manu-
facturer´s directions.
TaqMan real-time polymerase chain reaction (PCR)
Primers and probes. TaqMan real-time PCR [29, 30] prim-
ers and the TaqMan probe were designed using the Primer
Express Software (PE Applied Biosystems, Vienna, Aus-
tria). Primers were purchased from MWG Biotech (Eber-
sberg, Germany), probes were from Microsynth (Balgach,
Switzerland). For quantification of IL-1Ra mRNA, the
following primers were used: 5´-TCT CCT TCT CAT CCT
TCT GTT TCA T-3´, 5´-CTT GCA GGG TCT TTT CCC
AG-3´; the TaqMan probe 5’-CAG AGG CAG CCT GCC
GCC C-3’ was labeled with the reporter fluorescent dye
6-carboxyfluorescein (FAM) at the 5’ end and with the
quencher 6-carboxy-tetramethyl-rhodamine (TAMRA) at
the 3’ end. For quantification of IL-1Ra mRNA levels in
mouse hepatocytes, the TaqMan real-time PCR (Perkin
Elmer, Vienna, Austria) method was used. For the standard
curve, serially diluted mRNA prepared from mouse spleen
was subjected to reverse transcription as described above.
Generation of the standard curve and the PCR reaction
were performed as described elsewhere [31]. To minimize
intra-assay and interassay variability caused by differences
in reverse transcriptase efficiency, IL-1Ra quantities were
normalized to the amount of 18S-rRNA in specimens. For
18S-rRNA quantification, the 18S-rRNA reaction mix
(Perkin Elmer) was used.
Immunoblot analysis
Cells were lysed by adding 1X SDS sample buffer (62.5
mM Tris-HCl pH 6.8, 2% w/v SDS, 10% glycerol, 50 mM
DTT, 0.01% w/v bromophenol blue). Then, cell extracts
were sonicated for 15 seconds, heated to 95 °C for 5 min
and microcentrifuged for 5 min, before 20 lL of each
sample were loaded onto a 12.5% SDS-PAGE gel. After
the transfer blot, nitrocellulose membranes (Amersham,
UK) were washed with 25 mL TBS for 5 min at room
temperature (RT). Membranes were subsequently incu-
bated in 25 mL of blocking buffer (1X TBS, 0.1%
Tween-20 with 5% w/v nonfat dried milk) for 1h at RT.
Then, blots were washed three times with 1X TBS, 0.1%
Tween-20, before incubation with the primary antibody
(rabbit polyclonal IgG, affinity purified phospho-p44/42
MAPK Thr202/Tyr204, Cell Signaling Technology, USA).
After another three washing steps, membranes were incu-
bated with an HRP-conjugated secondary antibody (HRP
goat anti rabbit, DAKO, Denmark), washed three times
and subsequently incubated with SuperSignal West Pico
Chemiluminescent Substrate (Pierce, USA). Finally,
membranes were exposed to X-ray film (Amersham, UK).
Statistics
Data are presented as mean ± SEM. Statistical analysis was
performed using the nonparametric Wilcoxon test. p val-
ues less than 0.05 were considered to be significant.
RESULTS
Effects of HGF on IL-1Ra synthesis in HepG2 cells
HepG2 cells were cultured with HGF alone or in combi-
nation with IL-6 or IL-1b for 24 h. Stimulation with HGF
showed a dose-dependent pattern of IL-1Ra induction.
This effect was observed after stimulation with 1 ng/mL
HGF, and reached a maximum with 100 ng/mL HGF (3.4
ng/mL IL-1Ra versus 0.45 ng/mL in control supernatants)
(figure 1). Time course experiments with HGF alone (1
ng/mL; 10 ng/mL) showed an elevation of IL-1Ra levels
already after 2 h, reaching a maximum after 8 h (1 ng/mL)
and 12 h (10 ng/mL), respectively and then a slight decline
within 24 h (figure 2). Whereas IL-1Ra levels were unaf-
fected after stimulation with IL-6 alone, IL-6 slightly
potentiated the HGF-induced IL-1Ra production (data not
shown). HGF exhibited a strong synergistic effect on IL-
1b-induced IL-1Ra production (figure 3). IL-1b is known
to be a potent inducer of IL-1Ra production in HepG2 cells
and hepatocytes [32]. IL-1b at a concentration of 1 ng/mL
had a stronger stimulatory effect than HGF at any concen-
tration tested (0.1 to 100 ng/mL) (data not shown).
Effects of HGF on IL-1Ra mRNA expression
in HepG2 cells
HepG2 cells were incubated with increasing concentra-
tions of HGF (0.1 to 10 ng/mL) alone or in combination
with IL-6 or IL-1b for 4 h. RNA was isolated as described
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in Materials and methods. Culture medium alone caused a
weak expression of IL-1Ra, and HGF dose-dependently
upregulated IL-1Ra mRNA expression (figure 4A). IL-1b
was a potent inducer of IL-1Ra mRNA expression (figure
4B). In accordance with the protein data, costimulation
with HGF enhanced IL-1b-induced IL-1Ra mRNA levels
(figure 4B). IL-1Ra mRNA expression was unaffected
after incubation with IL-6 alone (data not shown), but
co-stimulation with HGF dose-dependently upregulated
IL-1Ra mRNA expression (data not shown).
Effects of HGF on IL-1Ra synthesis
in mouse hepatocytes
To see if the effects described above for a human hepato-
cellular carcinoma cell line could also be seen for primary
hepatocytes, we treated freshly isolated hepatocytes with
increasing concentrations of HGF (0.1, 10, 100 ng/mL) ±
IL-1b (1 ng/mL) for 24 h. HGF dose-dependently upregu-
lated the synthesis of IL-1Ra, an effect, which was found
even with 0.1 ng/mL HGF and reached a maximum with
100 ng/mL HGF (10.7 ng/mL IL-1Ra versus 7.9 ng/mL in
control supernatants) (figure 5). The high basal levels of
IL-1Ra, especially after stimulation with IL-1b (1 ng/mL),
masked the synergism between HGF and IL-1b on protein
accumulation in conditioned media, and a significant ef-
fect was only observed at the highest concentration tested
(15.4 ± 1.4 ng/mL IL-1Ra with IL-1b versus 16.6 ± 1.6
ng/mL IL-1Ra with IL-1b + 100 ng/mL HGF, P < 0.05)
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Figure 1
HGF induces IL-1Ra in HepG2 cells. HepG2 cells were cultured in
medium alone (open bar) or stimulated with HGF (grey bars) for
24 h. Values are expressed as mean ± SEM (n = 6); (*P < 0.05
compared to medium alone).
0
500
1 000
1 500
2 000
2 500
3 000
3 500
4 000
0h 2h 4h 8h 12h 24h
IL
-1
Ra
 (p
g/m
l)
HGF (1ng/mL)
HGF (10ng/mL)
Figure 2
Time course of IL-1Ra production. HepG2 cells were cultured with
HGF for 2, 4, 8, 12 and 24 h. Data represent mean ± SEM (n = 3).
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Figure 3
Synergistic effect of HGF on IL-1b-induced IL-1Ra production in
HepG2 cells. HepG2 cells were cultured in the absence or presence of
HGF (open bars), IL-1b (grey bar) or with a combination of HGF and
IL-1b (solid bars) for 24 h. Values are expressed as mean ± SEM
(n = 6); (*P < 0.05 compared to IL-1b alone).
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(data not shown). As shown for HepG2 cells, IL-1b at a
concentration of 1 ng/mL had a stronger stimulatory effect
than HGF at any concentration tested (0.1 to 100 ng/mL).
Effects of HGF on IL-1Ra mRNA expression
in mouse hepatocytes
Mouse hepatocytes were incubated with HGF alone, IL-1b
alone or with a combination of these two cytokines for 6 h.
HGF alone dose-dependently upregulated IL-1Ra mRNA
expression and significantly increased IL-1b-induced IL-
1Ra mRNA expression (figure 6). This clear synergistic
effect, in contrast to the only slight synergistic effect of
HGF on IL-1b-induced IL-1Ra protein synthesis, might be
explained by the sometimes high spontaneous and IL-1b-
induced IL-1Ra production at the protein level in murine
hepatocytes, which could have concealed the synergism
between HGF and IL-1b.
Effects of HGF on cytokine synthesis
and mRNA expression in human PBMC
PBMC were stimulated with LPS, PMA or PHA in the
absence or presence of increasing concentrations of HGF
(1 to 100 ng/mL). In addition, PBMC were preactivated
with PMA, PHA or LPS and subsequently stimulated with
HGF. After a 48 h incubation period, cell lysates were
analysed for IL-1Ra, IL-10 and TNF-a concentrations. In
all experiments performed HGF was not able to modulate
cytokine synthesis itself or to affect LPS-, PMA- or PHA-
induced cytokine synthesis (data not shown).
HGF alone was not able to upregulate the expression of
IL-1Ra mRNA or to affect the marked upregulation of
IL-1Ra mRNA expression observed with PMA and LPS
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Figure 4A
Induction of IL-1Ra mRNA expression by HGF in HepG2 cells.
HepG2 cells were cultured in medium alone (lane 1) or stimulated
with 0.1, 1 and 10 ng/mL HGF (lane 2, 3, 4, respectively). After 4 h,
total RNA was extracted, gel-electrophoresed, blotted onto nylon
membranes and hybridized with IL-1Ra and GAPDH probes.
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Figure 4B
Costimulatory effect of HGF on IL-1b-induced IL-1Ra mRNA ex-
pression in HepG2 cells. HepG2 cells were cultured in medium alone
(lane 1), or stimulated with 1 ng/mL IL-1b (lanes 2-4) in the absence
(lane 2) or presence of 1 and 10 ng/mL HGF (lane 3, 4, respectively).
After 4 h, total RNA was extracted, gel-electrophoresed, blotted onto
nylon membranes and hybridized with IL-1Ra and GAPDH probes.
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Figure 5
HGF induces IL-1Ra in mouse hepatocytes. Hepatocytes were cul-
tured in medium alone (open bar) or stimulated with HGF (grey bars)
for 24 h. Values are expressed as mean ± SEM (n = 6); (*P < 0.05
compared to medium alone).
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(data not shown). Moreover, HGF failed to modulate
PMA/PHA-induced TNF-a mRNA and IL-10 mRNA ex-
pression (data not shown). Also, after preactivation with
PMA, PHA or LPS, HGF had no effect on IL-1Ra, IL-10
and TNF-a mRNA expression (data not shown).
Modulation of signal transduction pathways by HGF
To study the mechanism underlying IL-1Ra induction by
HGF, we investigated the modulatory potential of this
cytokine on signal transduction pathways underlying IL-
1Ra expression. To this end, we first studied the effects of
pharmacological inhibition of signal transduction pro-
cesses by analysing the influence of the MAPK inhibitors,
MEK-1 inhibitor PD98059 and p38-MAPK inhibitor
SB203580 on HGF-mediated IL-1Ra induction in HepG2
cells. By treatment with PD98059 (1 to 35 lM), HGF-
induced IL-1Ra synthesis was significantly decreased.
This effect was already seen with 1 lM and reached a
maximum with 35 lM (figure 7). However, treatment with
the p38-MAPK inhibitor SB203580 (35 lM) had no
significant effect on HGF-induced IL-1Ra synthesis
(figure 7).
In order to further elucidate the regulatory network be-
tween HGF and signal transduction processes, we per-
formed Western blot experiments using an antibody di-
rected against phosphorylated p42/44 MAPK. As can be
seen in figure 8, HGF specifically and rapidly stimulated
the phosphorylation of p42/44 in HepG2 but not in THP-1
human monocytic cells (not shown).
DISCUSSION
HGF, originally described as a potent mitogen for hepato-
cytes, has, in recent years, been identified as a multifunc-
tional cytokine. HGF exerts protective actions in several
acute phase models and is able to prevent acute liver injury
in rats. Nevertheless, the regenerative effect of HGF is not
liver-specific as it has also been detected in the gastrointes-
tinal tract [33] and in the kidney [34]. HGF has also been
shown to possess cytoprotective effects on hepatocytes
during hepatitis caused by hepatotoxins such as
a-naphthylisothyocyanate or CCL4 in various animal
models [8, 9]. Consistent with this anti-hepatitis effect of
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Figure 6
HGF induces IL-1Ra mRNA expression in mouse hepatocytes and
potentiates IL-1b-induced IL-1Ra mRNA expression. Hepatocytes
were cultured in the absence or presence of HGF (ng/mL) (open
bars), IL-1b (1 ng/mL) (grey bar) or with a combination of HGF and
IL-1b (solid bars). After 6 h, total RNA was isolated and PCR
performed as described in Material and methods. Values are ex-
pressed as mean ± SEM (n = 6); (*P < 0.05 compared to medium
alone and **P < 0.05 compared to IL-1b alone).
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Figure 7
Suppression of HGF-mediated IL-1Ra induction by MEK-1 inhibitor
PD98059 in HepG2 cells. HepG2 cells were cultured in the absence
or presence of HGF (10 ng/mL) (open bars) or treated with HGF
(10 ng/mL) + PD98059 (35 lM) or HGF(10 ng/mL) + SB203580 (35
lM) (grey bars) for 24 h. Values are expressed as mean ± SEM (n
= 4); (*P < 0.05 compared to HGF alone).
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Figure 8
HGF induces the phosphorylation of stress-induced MAPK. HepG2
cells were stimulated with the indicated dosages of HGF for 15 to 60
min or left untreated. Total protein lysates were then prepared, and
Western blotting for the stress-induced MAPK p42/44 (MEK1/2)
was carried out as detailed in Materials and methods. One of three
representative experiments is shown.
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HGF in vivo, elevated HGF mRNA expression could be
detected in liver biopsies from patients with acute alco-
holic hepatitis, and a positive correlation between elevated
HGF serum levels and hepatocyte proliferation in the biop-
sies was demonstrated [35, 36]. Hemodialysis is associ-
ated with elevated HGF serum levels [37]. In hepatitis C
virus positive patients, subjected to hemodialysis, liver
damage caused by the hepatitis C virus was reduced com-
pared to hepatitis C virus-positive patients without renal
disease and lower HGF serum levels, suggesting that HGF
may be responsible for this anti-hepatitis effect in vivo
[37]. It has been reported that HGF has a protective effect
on interferon gamma (IFN-c)-induced cytotoxicity in
mouse hepatocytes [38]. HGF inhibits DNA fragmentation
induced by IFN-c in primary cultures of hepatocytes, sug-
gesting that HGF inhibits apoptosis caused by IFN-c [38].
Some of the potential mechanisms involved in the anti-
hepatitis properties of HGF have been identified. Okano et
al. provided evidence that this protective effect might be
mediated via increased hepatic PG E2 production [10].
Kosai et al. showed that HGF inhibits excessive activation
of Fas and Fas ligand by blocking the Fas-mediated signal
pathway, which plays a key role in the development of
fulminant hepatic failure caused by hepatitis virus infec-
tion or endotoxin [11]. Additionally, HGF induces Bcl-xL
mRNA expression and protein synthesis in the liver, a
protein belonging to the family of the proto-oncogene
Bcl-2, which has an inhibitory effect on Fas-mediated cell
death [11].
As cytokines are involved in various models of acute liver
failure [14, 15], we thought that modulation of cytokine
synthesis by HGF in HepG2 cells and hepatocytes could be
a mode of action for its protective effects. HepG2 cells, a
hepatoma cell line widely used for the study of acute phase
proteins such as IL-1Ra, retain many functions of paren-
chymal hepatocytes and have been shown to express the
high affinity c-met HGF receptor [39]. Systemic inflam-
mation is associated with elevated IL-1 and IL-6 levels
resulting in a systemic acute phase response. IL-1 plays a
key role in the pathogenesis of chronic inflammation and
septic shock [40]. IL-6 regulates a broad spectrum of acute
phase proteins in the liver and is an important component
of signaling pathways leading to liver regeneration [41].
Primary hepatocytes as well as HepG2 cells, have been
previously shown to express mRNA encoding for the se-
creted form of IL-1Ra, but not for intracellular IL-1Ra [42,
43]. We show here that HepG2 cells and mouse hepato-
cytes synthesized IL-1Ra when stimulated with HGF, and
that this effect was potentiated especially after co-culture
with IL-1b. Based on the findings that HGF serum levels
and HGF mRNA expression in the liver increase markedly
following acute hepatitis, one may speculate that HGF
exerts, at least partially, its regenerative ability by induc-
tion of anti-inflammatory cytokines such as IL-1Ra [44,
45]. Our data provide further evidence for a role of HGF in
the interaction between the stromal environment and
mononuclear cells, as polymorphonuclear cells have been
identified as a source of HGF in patients with alcoholic
hepatitis [46] and HGF has been shown to be able to
control the immunmodulatory functions of monocytes by
induction of IL-6 [47].
Several signalling events have been reported after HGF
receptor activation [48-51]. MAP kinases are thought to be
implicated in a variety of cellular functions such as arachi-
donic acid release and cell growth [52, 53]. It has been
shown that HGF activated MAP kinases and arachidonic
acid release in primary cultured rat hepatocytes [54, 55].
We show here that MEK-1 inhibitor PD98059 decreases
the HGF-induced IL-1Ra synthesis in HepG2 cells. Ac-
cordingly, HGF specifically increased the phosphorylation
of MAPK p42/44 (MEK1/2) in HepG2 cells indicating that
HGF modulates IL-1Ra expression by stimulating stress-
induced MAPK signalling cascades.
Another mode of action for the anti-inflammatory effects
of HGF might be the regulation of pro- and anti-
inflammatory cytokines in monocytes. Galimi et al.
showed that endotoxin- and IL-1b-activated monocytes
clearly expressed the HGF receptor, while the receptor
transcript was barely detectable in nonactivated mono-
cytes. Secretion of biologically active HGF by activated
monocytes implies an autocrine stimulation [47]. In our
experiments we used an approach similar to that used by
Beilmann et al. [23], preactivating monocytes with PHA,
PMA and LPS and then simulating with HGF. We found
however, no effects of HGF on IL-1Ra, TNF-a and IL-10
mRNA expression or protein synthesis. In contrast to the
data obtained for HepG2 cells, no phosphorylation of
MAPK p42/44 (MEK1/2) was observed in the human
monocytic cell line THP-1. These results might explain the
different effects of HGF on IL-1Ra production in hepato-
cytes versus monocytes.
Besides the anti-hepatitis effect, HGF is thought to play an
important role in suppressing the onset of hepatic fibrosis
induced by different hepatotoxins [56]. As shown in a rat
model, HGF gene therapy caused a complete resolution of
fibrosis induced by dimethylnitrosamine [57]. In this
study, repeated administration of HGF suppressed the ex-
pression of transforming growth factor (TGF)-b1 mRNA
induced by dimethylnitrosamine. TGF-b1 is known to play
a major role in the progression of liver cirrhosis [57]. Also
IL-1Ra has been demonstrated to limit dimethyl-
nitrosamine-induced fibrosis in vivo by competitively
blocking the binding of IL-1 to its receptor [58]. Our data
suggest that the protective and regenerative properties of
HGF observed in several animal models might be partially
mediated by its ability to regulate synthesis of IL-1Ra, a
natural by occurring inhibitor of inflammation.
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